Ciprofloxacin: a study of usage in pedal infections with case reports.
Ciprofloxacin, an antibiotic of the quinolone class, has exhibited properties that may lead to frequent use in the febrile patient. Particularly important to the podiatrist is the bactericidal action of the drug on penicillinase producing Staphylococcus aureus and Pseudomonas species. Ciprofloxacin also kills many Gram-negative bacteria, and some anaerobic bacteria. Infections of this nature have been classically treated with parenteral antibiotics in a hospital setting. Ciprofloxacin has demonstrated, in clinical studies, the ability to kill these organisms in skin, soft tissues, and bone while using an oral route of administration. When considering cost-containment strategies in the patient with osteomyelitis, ciprofloxacin can cost between 50% to 80% less than parenteral therapy.
Notari
M A
MA
Mittler
B E
BE
D002939:Ciprofloxacin / Q000627:therapeutic use*; D005260:Female; D005534:Foot Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000188:drug therapy; D012883:Skin Ulcer / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013530:Surgical Wound Infection / Q000188:drug therapy
D002939:Ciprofloxacin